Hedge Fund - Kingdon Capital

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...

Mark Kingdon founded Kingdon Capital, a New York-based macro and long/short hedge fund, in 1983 with $2 million in assets under management (AUM).

In two new filings with the U.S.

Mark Kingdon’s Kingdon Capital recently disclosed an increase in its exposure to Dipexium Pharmaceuticals Inc (NASDAQ:DPRX).

Many billionaire investors have been bracing themselves for a market correction, but George Soros may be worth an extra look.

In the current round of 13F filings, hedge funds and other institutional investors are disclosing their equity portfolios as held at the end of the last year.

To many investors, hedge funds are viewed as delayed, outdated financial vehicles of a forgotten age.

In the eyes of many of your fellow readers, hedge funds are seen as overrated, old investment vehicles of an era lost to time.